We demonstrated with the studied patient cohort and the conditional cell model that expression of ESRP1 in CRC tumor cells is associated with a shift in EMT splicing patterns of ENAH and CTNND1 (p120-catenin) [10], thus confirming a key role of ESRPs in CRC progression. Here, ESRP1 is linked to neoplasm.